Clorox Company (The) (CLX) traded higher in the last at $120.15, gaining 0.15 points or 0.13%. From the data available, it can be said that the stock did not make an impact in the money flow department with the net figure coming to be $(-1.35) million. The composite uptick value of $3.77 million was eclipsed by the accrued downtick value of $5.13 million, thereby ensuring the up/down ratio of 0.74. For the week, the shares have posted returns of -0.28%.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
The Clorox Company has dropped 0.61% in the last five trading days, however, the shares have posted positive gains of 1.26% in the last 4 weeks. The Clorox Company is up 1.26% in the last 3-month period. Year-to-Date the stock performance stands at 1.26%. Clorox Company (The) (NYSE:CLX) rose 0.61% or 0.73 points on Wednesday and made its way into the gainers of the day. After trading began at $119.64 the stock was seen hitting $121 as a peak level and $119.57 as the lowest level. The stock ended up at $120.73. The daily volume was measured at 1,036,343 shares. The 52-week high of the share price is $140.47 and the 52-week low is $111.24. The company has a market cap of $15,543 million.
Company has reported several Insider transactions to the SEC, on Dec 2, 2016, A D David Mackay (director) purchased 5,000 shares at 114.90 per share price.On Sep 7, 2016, Laura Stein (EVP – General Counsel) sold 38,882 shares at 131.69 per share price.On Aug 31, 2016, Jon M Balousek (SVP – GM, Specialty Div) sold 5,136 shares at 131.14 per share price.
Clorox Co Last issued its quarterly earnings results on Nov 2, 2016. The company reported $1.36 EPS for the quarter, missing the analyst consensus estimate by $ -0.06. Analyst had a consensus of $1.42. The company had revenue of $1443.00 million for the quarter, compared to analysts expectations of $1428.44 million. The companys revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.32 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Clorox Co was Upgraded by Barclays on Jan 9, 2017 to Equal Weight, Lowers Price Target to $ 111 from a previous price target of $115 .Clorox Co was Upgraded by Morgan Stanley to Equal-Weight on Dec 16, 2016. Clorox Co was Resumed by Wells Fargo to Market Perform on Nov 15, 2016.
Clorox Companys business operations, represented by the aggregate of its U.S. Household Products and Canada, U.S. Specialty Products and International segments, include the production and marketing of non-durable consumer products sold primarily through grocery and other retail stores.